MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
Okta COO Frederic Kerrest wants you to know that not every business success story is a fairytale.
Founded by 4 MIT students, DeepBench wants to match clients and advisers faster and better than ever before.
Provides an overview of the Foreign Corrupt Practices Act (FCPA), introduces discussion of the legal and ethical issues than can arise when operating internationally, and helps students identify internal control weaknesses in a firm and how these weaknesses can lead to misconduct, fraud, or illegal ...
Hosted by MIT Sloan and run by the MIT Sloan Sustainability Initiative, the event was the largest (and first-ever carbon-neutral!) ClimateCAP MBA Summit, bringing together nearly 400 MBA students from more than 45 business schools. Over the weekend, what stood out most wasn’t any single idea or solu...
Expanding access to capital for women and entrepreneurs of color requires deliberate and concrete action, not optics.
At Generate Capital, Yancan “Lydia” Li proves the potential of impact investing through successful projects and real metrics.
A peer-reviewed research paper from MIT Sloan School of Management assistant professor Rahul Bhui takes a new look at rational inattention—a theory that argues we process information based on how we “
New research forecasts the effect of two-dose vaccine strategies on the cumulative number of infections and deaths in the U.S.
Their approach helps the supply side of the economy “snap back” in the second phase of the crisis. The key is creating a master agreement that provides a win-win solution for all parties.
